Article Details

Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates

Retrieved on: 2020-12-08 13:20:21

Tags for this article:

Click the tags to see associated articles and topics

Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates. View article details on hiswai:

Excerpt

Then Bruce Booth at <b>Atlas Venture</b> mentioned a couple of TREM2 assets he was trying to snag from Amgen's old neuroscience pipeline. Bruce Booth.

Article found on: endpts.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up